Cardiovascular
Cardiovascular Disease
CROI 2017: Long-Term Darunavir/Ritonavir Modestly Increases Risk of Cardiovascular Disease
- Details
- Category: Cardiovascular Disease
- Published on Thursday, 16 March 2017 00:00
- Written by Michael Carter
Long-term use of the boosted protease inhibitor darunavir (Prezista) modestly increases the risk of cardiovascular disease, according to data from the ongoing D:A:D study presented to the recent Conference on Retroviruses and Opportunistic Infections. Investigators identified an independent association between cumulative use of the drug over 5 years and heart attack and stroke.
CROI 2017: Stopping Smoking Cuts Risk of Some Cancers Quickly in People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 20 February 2017 00:00
- Written by Keith Alcorn
Smoking probably contributes far more to the risk of cardiovascular disease in people with HIV than antiretroviral drug choice, viral load, or any factor linked to the virus, but stopping smoking leads to a rapid reduction in the risk of some cancers, according to results from a cluster of studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections last week in Seattle.
CROI 2016: HIV-Related Factors Increase Risk of Stroke
- Details
- Category: Cardiovascular Disease
- Published on Tuesday, 08 March 2016 00:00
- Written by Theo Smart
HIV-related risk factors seem to increase the risk of stroke -- the sudden death of brain cells due to a rupture or obstruction of blood vessels in the brain -- according to ongoing research in a growing number of large epidemiological cohort studies. Recent data from 5 of these were presented during the first-ever poster discussion session on stroke at the Conference on Retroviruses and Opportunistic Infections (CROI), which took place last month in Boston.
CROI 2016: Women and African Americans with HIV Have a Higher Risk of Stroke
- Details
- Category: Cardiovascular Disease
- Published on Wednesday, 23 March 2016 00:00
- Written by Keith Alcorn & Michael Carter
The risk of stroke among people living with HIV is highest among people with unsuppressed viral load, and among women and African Americans, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016)last month in Boston.
CROI 2016: Early Antiretroviral Therapy Has No Impact on Cardiovascular Disease Marker
- Details
- Category: Cardiovascular Disease
- Published on Friday, 04 March 2016 00:00
- Written by Keith Alcorn
Starting treatment at a CD4 cell count above 500 cells/mm3 does not lead to improvement in an important early warning sign of cardiovascular disease, and investigators are still unsure whether people who start treatment at high CD4 counts will have the same increased risk of cardiovascular disease as that reported in people with HIV over the past 15 years, according to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston last week.
Web Design and Development by